Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening

Zhongguang Luo(Fudan University), Jie Liu(Qingdao University), Bing Zhao(Fudan University), Bangting Wang(Fudan University), Jinsong Wei(Fudan University), Yujen Tseng(Fudan University), Xin Wang(Jiangsu University), Jian Chen(Fudan University), Ning Jiang(Fudan University), Yumeng Guo(Fudan University), Feifei Luo(Jiangxi University of Traditional Chinese Medicine)
BMC Medicine
September 4, 2023
10.1186/s12916-023-03034-y
Cited by 44

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
A Comparison of Whole-Genome Shotgun-Derived Mouse Chromosome 16 and the Human Genome
|Science|2002|370
BMP restricts stemness of intestinal Lgr5+ stem cells by directly suppressing their signature genes
|Nature Communications|2017|323
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
|Journal of Neuroinflammation|2018|264
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
|Journal of Hematology & Oncology|2020|183